In the wake of the health shock, what are the challenges posed to R&I teams by the hybrid organization in which face-to-face collaboration is no longer the norm?
Read our recap of the first online debate hosted by Presans, featuring Greg Cochran and Robin Hanson. Should we expose ourselves voluntarily to COVID-19?
Disruptive biotechnological innovations are here and are evolving rapidly, driven by obvious but also hidden proactive strategies.
COVID-19 reveals Western vulnerabilities and this crisis will lead to an update of our health systems.